Ouellet Gregory M, Ouellet Jennifer A, Tinetti Mary E
Section of Geriatrics, Department of Internal Medicine, Yale School of Medicine, 367 Cedar Street, Harkness A, Room 308-A, New Haven, CT 06520-8093, USA.
Section of Geriatrics, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Ther Adv Drug Saf. 2018 Aug 9;9(11):639-652. doi: 10.1177/2042098618791371. eCollection 2018 Nov.
Although the majority of older adults in the developed world live with multiple chronic conditions (MCCs), the task of selecting optimal treatment regimens is still fraught with difficulty. Older adults with MCCs may derive less benefit from prescribed medications than healthier patients as a result of the competing risk of several possible outcomes including, but not limited to, death before a benefit can be accrued. In addition, these patients may be at increased risk of medication-related harms in the form of adverse effects and significant burdens of treatment. At present, the balance of these benefits and harms is often uncertain, given that older adults with MCCs are often excluded from clinical trials. In this review, we propose a framework to consider patients' own priorities to achieve optimal treatment regimens. To begin, the practicing clinician needs information on the patient's goals, what the patient is willing and able to do to achieve these goals, an estimate of the patient's clinical trajectory, and what the patient is actually taking. We then describe how to integrate this information to understand what matters most to the patient in the context of an array of potential tradeoffs. Finally, we propose conducting serial therapeutic trials of prescribing and deprescribing, with success measured as progress towards the patient's own health outcome goals. The process described in this manuscript is truly an iterative process, which should be repeated regularly to account for changes in the patient's priorities and clinical status. With this process, we aim to achieve optimal prescribing, that is, treatment regimens that maximize benefits that matter to the patient and minimize burdens and potential harms.
尽管发达国家的大多数老年人都患有多种慢性病(MCCs),但选择最佳治疗方案的任务仍然充满困难。患有MCCs的老年人从处方药中获得的益处可能比健康患者少,这是由于存在几种可能结果的竞争风险,包括但不限于在获得益处之前死亡。此外,这些患者可能因不良反应和重大治疗负担而面临与药物相关伤害的风险增加。目前,鉴于患有MCCs的老年人通常被排除在临床试验之外,这些益处和危害之间的平衡往往不确定。在本综述中,我们提出了一个框架,以考虑患者自身的优先事项,从而实现最佳治疗方案。首先,执业临床医生需要了解患者的目标、患者为实现这些目标愿意且能够做的事情、对患者临床轨迹的估计以及患者实际正在服用的药物。然后,我们描述如何整合这些信息,以便在一系列潜在权衡的背景下理解对患者最重要的是什么。最后,我们建议进行一系列的处方和撤药治疗试验,以朝着患者自身的健康结果目标取得进展来衡量成功与否。本手稿中描述的过程确实是一个迭代过程,应定期重复以考虑患者优先事项和临床状况的变化。通过这个过程,我们旨在实现最佳处方,即最大化对患者重要的益处、最小化负担和潜在危害的治疗方案。